ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced that the first participants have been dosed in a Phase 1 clinical trial evaluating MDX2301 for the prevention of COVID-19 ...

Invivyd (NASDAQ:IVVD) provided updates on its REVOLUTION program for COVID-19 monoclonal antibody candidate VYD2311 and ...

The drug, which Invivyd sees as a potential treatment and “targeted alternative” for the vaccine-hesitant, comes as measles ...

C4 Therapeutics (NASDAQ:CCCC) shares climbed about 10% after the company announced a broadened partnership with Roche (SIX:RO ...

C4 Therapeutics said on Thursday it has entered into a deal ​focused on research and development of ‌a type of cancer drug ...

Roche has joined its Big Pharma peers in the emerging degrader-antibody conjugate (DAC) space, paying C4 Therapeutics $20 ...

Kainova Therapeutics (“the Company”), a key player for breakthrough treatments in immuno-oncology and inflammation, today announced dosing of the first patient in the European expansion of its DOMISOL ...

Antibody therapeutics are laboratory-made proteins designed to work like the body's natural antibodies. They are widely used ...

Backed by OrbiMed, Novartis’ venture arm and many other investors, the biotech is among those working on newer technology ...

The funding round, led by Novartis and OrbiMed, will allow Sidewinder to progress two of its bispecific ADC programmes to ...

Oncology biotech Akari Therapeutics has announced a partnership with WuXi XDC, an antibody-drug conjugate (ADC) development ...

U.S. Olympic gold medal-winning athlete Lindsey Vonn is once again teaming up with infectious disease biopharma Invivyd for a ...